« Previous
Next »
Neurobiology of Aging
Volume 30, Issue 5
, Pages 759-768
, May 2009
Screening of innate immune receptors in neurodegenerative diseases: A similar pattern
References
- . Innate immunity and toll-like receptors: clinical implications of basic science research. J. Pediatr. 2004;144(4):421–429
- . Inflammation and Alzheimer's disease. Neurobiol. Aging. 2000;21(3):383–421
- . HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat. Med. 2000;6(4):435–442
- . Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J. Biol. Chem. 2002;277(17):15028–15034
- Mechanisms of amyloid deposition in Alzheimer's disease. Ann. N.Y. Acad. Sci. 1991;640:129–139
- . Broad expression of Toll-like receptors in the human central nervous system. J. Neuropathol. Exp. Neurol. 2002;61(11):1013–1021
- . Activation of Toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid beta peptide. J. Biol. Chem. 2006;281(6):3651–3659
- . Early onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J. Biol. Chem. 2001;276(24):21562–21570
- . Mechanisms of neurodegeneration in amyotrophic lateral sclerosis. Mol. Pathol. 2001;54(6):386–392
- . Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am. J. Pathol. 1994;145(6):1271–1279
- . Intrahippocampal LPS injections reduce Abeta load in APP
+
PS1 transgenic mice. Neurobiol. Aging. 2001;22(6):1007–1012 - . Inflammation occurs early during the Abeta deposition process in TgCRND8 mice. Neurobiol. Aging. 2004;25(7):861–871
- . Inflammatory response after open heart surgery: release of heat-shock protein 70 and signaling through toll-like receptor-4. Circulation. 2002;105(6):685–690
- . Molecular pathogenesis of Parkinson disease. Arch. Neurol. 2005;62(3):353–357
- . The LPS receptor (CD14) links innate immunity with Alzheimer's disease. FASEB J. 2004;18(1):203–205
- . The role of heat shock proteins Hsp70 and Hsp27 in cellular protection of the central nervous system. Int. J. Hyperthermia. 2005;21(5):379–392
- . Tau phosphorylation increases in symptomatic mice overexpressing A30P alpha-synuclein. Exp. Neurol. 2005;192(2):274–287
- . Transgenic-mouse model of amyotrophic lateral sclerosis. N. Engl. J. Med. 1994;331(25):1721–1722
- Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science. 1994;264(5166):1772–1775
- . Time-dependent reduction in Abeta levels after intracranial LPS administration in APP transgenic mice. Exp. Neurol. 2004;190(1):245–253
- . CpG-containing oligodeoxynucleotide promotes microglial cell uptake of amyloid beta 1-42 peptide by up-regulating the expression of the G-protein-coupled receptor mFPR2. FASEB J. 2005;19(14):2032–2034
- . Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha-synuclein in human and transgenic mouse brain. J. Neurosci. 2000;20(17):6365–6373
- . Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model. Am. J. Pathol. 2001;159(6):2215–2225
- . Microglial activation and amyloid-beta clearance induced by exogenous heat-shock proteins. FASEB J. 2002;16(6):601–603
- . Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. J. Neurosci. 2005;25(39):8843–8853
- . Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J. Neurosci. 2007;27(6):1405–1410
- . Adverse effect of a presenilin-1 mutation in microglia results in enhanced nitric oxide and inflammatory cytokine responses to immune challenge in the brain. Neuromol. Med. 2002;2(1):29–45
- . Innate immune receptor expression in normal brain aging. Neuroscience. 2007;146(1):248–254
- . LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide. Brain. 2005;128(Pt 8):1778–1789
- . Molecular pathophysiology of Parkinson's disease. Annu. Rev. Neurosci. 2005;28:57–87
- . Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis. J. Neurosci. 2004;24(6):1340–1349
- . The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc. Natl. Acad. Sci. U.S.A. 2000;97(25):13766–13771
- . Toll-like receptors and their role in experimental models of microbial infection. Genes Immun. 2003;4(2):87–94
- . The molecular pathology of Alzheimer's disease. Neuron. 1991;6(4):487–498
- . Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 2001;81(2):741–766
- . Role of toll-like receptor signalling in A{beta} uptake and clearance. Brain. 2006;129(Pt 11):3006–3019
- . Recognition of lipopeptides by toll-like receptors. J. Endotoxin Res. 2002;8(6):459–463
- . Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation. Cell Tissue Res. 2004;318(1):149–161
- . The microglial “activation” continuum: from innate to adaptive responses. J. Neuroinflammation. 2005;2:24
- . Pathogen-associated molecular pattern contamination as putative endogenous ligands of toll-like receptors. J. Endotoxin Res. 2007;13(1):6–14
- . Toll-like receptors: networking for success. Eur. J. Immunol. 2003;33(7):1767–1775
- . HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J. Biol. Chem. 2002;277(17):15107–15112
- . The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway. J. Biol. Chem. 2002;277(23):20847–20853
- . Heat shock proteins as ligands of toll-like receptors. Curr. Top. Microbiol. Immunol. 2002;270:169–184
- . The LPS receptor, CD14 in experimental autoimmune encephalomyelitis and multiple sclerosis. Cell Physiol. Biochem. 2006;17(3–4):167–172
PII: S0197-4580(07)00344-2
doi: 10.1016/j.neurobiolaging.2007.08.018
© 2007 Elsevier Inc. All rights reserved.
« Previous
Next »
Neurobiology of Aging
Volume 30, Issue 5
, Pages 759-768
, May 2009
